Page last updated: 2024-10-23

bendroflumethiazide and Arteriosclerosis, Coronary

bendroflumethiazide has been researched along with Arteriosclerosis, Coronary in 1 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Macfarlane, TV1
Pigazzani, F1
Flynn, RWV1
MacDonald, TM1

Reviews

1 review available for bendroflumethiazide and Arteriosclerosis, Coronary

ArticleYear
The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:2

    Topics: Bendroflumethiazide; Blood Pressure; Coronary Artery Disease; Diuretics; Humans; Hypertension; Indap

2019